, Tracking Stock Market Picks
Enter Symbol:
Endologix Inc (ELGX) [hlAlert]

down 4.35 %

Endologix Inc (ELGX) rated Buy with price target $17.50 by Canaccord Genuity

Posted on: Friday,  Feb 28, 2014  11:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Endologix Inc (NASDAQ: ELGX) on 02/28/2014, when the stock price was $13.55. Since
then, Endologix Inc has lost 4.35% as of 01/14/2016's recent price of $12.96.
If you would have followed this Canaccord Genuity's recommendation on ELGX, you would have lost 4.35% of your investment in 685 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 11:25 AM Buy
13.55 17.50
as of 10/17/2014
1 Week up  4.04 %
1 Month down  -19.43 %
3 Months down  -19.94 %
1 YTD down  -16.45 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy